Brief: Adverum Biotechnologies Receives Nasdaq Notice On Regained Compliance With Minimum Bid Price Requirement
14/06/2023 21:08
June 14 (Reuters) - Adverum Biotechnologies Inc
ADVM.O :
* ADVERUM BIOTECHNOLOGIES INC - ON JUNE 13, CO RECEIVED
WRITTEN
FROM NASDAQ STATING THAT CO HAS REGAINED COMPLIANCE WITH MINIMUM
BID PRICE REQUIREMENT
Further company coverage: ADVM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)